These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29782959)

  • 1. Targeting central β2 receptors ameliorates streptozotocin-induced neuroinflammation via inhibition of glycogen synthase kinase3 pathway in mice.
    Abdel Rasheed NO; El Sayed NS; El-Khatib AS
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():65-75. PubMed ID: 29782959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Effect of Biobran/MGN-3 against Sporadic Alzheimer's Disease Mouse Model: Possible Role of Oxidative Stress and Apoptotic Pathways.
    Ghoneum MH; El Sayed NS
    Oxid Med Cell Longev; 2021; 2021():8845064. PubMed ID: 33574982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
    Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
    Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
    Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
    Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice.
    Liu C; Wu Y; Zha S; Liu M; Wang Y; Yang G; Ma K; Fei Y; Zhang Y; Hu X; Yang W; Qian Y
    Brain Res; 2016 Jan; 1631():137-46. PubMed ID: 26656068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α7nAChR activation protects against oxidative stress, neuroinflammation and central insulin resistance in ICV-STZ induced sporadic Alzheimer's disease.
    Yamini P; Ray RS; Yadav S; Dhaliwal J; Yadav M; Kondepudi KK; Chopra K
    Pharmacol Biochem Behav; 2022 Jun; 217():173402. PubMed ID: 35533773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paeonol Ameliorates Cognitive Deficits in Streptozotocin Murine Model of Sporadic Alzheimer's Disease via Attenuation of Oxidative Stress, Inflammation, and Mitochondrial Dysfunction.
    Tayanloo-Beik A; Kiasalari Z; Roghani M
    J Mol Neurosci; 2022 Feb; 72(2):336-348. PubMed ID: 34797511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of valproic acid in streptozotocin-induced sporadic Alzheimer's disease mouse model: possible involvement of the cholinergic system.
    Sorial ME; El Sayed NSED
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):581-593. PubMed ID: 28188358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-(2-benzofuranyl)-2-imidazoline (2-BFI) improved the impairments in AD rat models by inhibiting oxidative stress, inflammation and apoptosis.
    Tian JS; Zhai QJ; Zhao Y; Chen R; Zhao LD
    J Integr Neurosci; 2017; 16(4):385-400. PubMed ID: 28891528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canagliflozin Mitigated Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer's Disease in Mice: Role of AMPK/SIRT-1 Signaling Pathway in Modulating Neuroinflammation.
    Khamies SM; El-Yamany MF; Ibrahim SM
    J Neuroimmune Pharmacol; 2024 Jul; 19(1):39. PubMed ID: 39073453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
    J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.
    Shi L; Zhang Z; Li L; Hölscher C
    Behav Brain Res; 2017 Jun; 327():65-74. PubMed ID: 28342971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress.
    Ali MR; Abo-Youssef AM; Messiha BA; Khattab MM
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):637-56. PubMed ID: 27026404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model.
    Guo Z; Chen Y; Mao YF; Zheng T; Jiang Y; Yan Y; Yin X; Zhang B
    Sci Rep; 2017 Apr; 7():45971. PubMed ID: 28382978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway.
    Akhtar A; Dhaliwal J; Saroj P; Uniyal A; Bishnoi M; Sah SP
    Inflammopharmacology; 2020 Apr; 28(2):385-400. PubMed ID: 31898080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment.
    Tota S; Kamat PK; Shukla R; Nath C
    Behav Brain Res; 2011 Aug; 221(1):207-15. PubMed ID: 21382422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plumbagin ameliorates memory dysfunction in streptozotocin induced Alzheimer's disease via activation of Nrf2/ARE pathway and inhibition of β-secretase.
    Nakhate KT; Bharne AP; Verma VS; Aru DN; Kokare DM
    Biomed Pharmacother; 2018 May; 101():379-390. PubMed ID: 29501041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological targeting of β
    O'Neill E; Yssel JD; McNamara C; Harkin A
    Br J Pharmacol; 2020 Jan; 177(2):282-297. PubMed ID: 31506926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA Mediated GSK3β Knockdown Targets Insulin Signaling Pathway and Rescues Alzheimer's Disease Pathology: Evidence from
    Gupta S; Singh V; Ganesh S; Singhal NK; Sandhir R
    ACS Appl Mater Interfaces; 2022 Jan; 14(1):69-93. PubMed ID: 34967205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.